| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/25/2007 | EP1810681A1 Intestinal polyp inhibitor |
| 07/25/2007 | EP1810680A2 Compositions and methods for use in targeting vascular destruction |
| 07/25/2007 | EP1809673A2 Modulators of hepatocyte growth factor activator |
| 07/25/2007 | EP1809669A2 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 07/25/2007 | EP1809636A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 07/25/2007 | EP1809630A1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 07/25/2007 | EP1809629A1 N,n'-diphenyl urea derivatives suitable as kinase inhibitors |
| 07/25/2007 | EP1809628A1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 07/25/2007 | EP1809622A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/25/2007 | EP1809621A1 Methods of preparing indazole compounds |
| 07/25/2007 | EP1809618A1 Chroman derivatives, medicaments and use in therapy |
| 07/25/2007 | EP1809612A1 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 07/25/2007 | EP1809603A1 Nitrobenzindoles and their use in cancer therapy |
| 07/25/2007 | EP1809334A2 Conjugates with enhanced cell uptake activity |
| 07/25/2007 | EP1809332A2 Compositions for multi-step delivery of hot-spots radiation to cancer cells |
| 07/25/2007 | EP1809330A2 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 07/25/2007 | EP1809315A1 Inhibition of tumor growth and metastasis by atf2-derived peptides |
| 07/25/2007 | EP1809314A2 Class iii slrp for the treatment of cancer |
| 07/25/2007 | EP1809282A2 Thiadiazole compounds and methods of use |
| 07/25/2007 | EP1809281A2 Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
| 07/25/2007 | EP1809279A1 Nanoparticulate compositions of tubulin inhibitor |
| 07/25/2007 | EP1809278A2 Combinations of pkc activators and pkc inhibitors for for alzheimer's disease treatment and cognitive enhancement |
| 07/25/2007 | EP1809275A1 Chemical compounds |
| 07/25/2007 | EP1809266A2 Anticancer compounds and methods |
| 07/25/2007 | EP1809240A2 Cardiac safe, rapid medication delivery |
| 07/25/2007 | EP1553933B1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 07/25/2007 | EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1496076B1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| 07/25/2007 | EP1444236B1 Separation of regioisomers of metal phthalocyanines |
| 07/25/2007 | EP1427383B1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1330273B1 Coated implantable medical device |
| 07/25/2007 | EP1263763B1 Tubulin binding ligands |
| 07/25/2007 | EP1212621B1 Screening for agents modulating tgf-beta cell signalling |
| 07/25/2007 | EP1200594B1 Protective antigen of epstein barr virus |
| 07/25/2007 | EP1143985B1 Use of lactobacillus salivarius |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | EP0820281B1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses |
| 07/25/2007 | CN1328382C Recombination expression method for black porgy tumor necrosis factor alph gene |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328372C Tumor target gene-virus ZD55-IL-24, construction method and application thereof |
| 07/25/2007 | CN1328291C 新的脱乙酰壳多糖 The new chitosan |
| 07/25/2007 | CN1328289C Endothelium chalone capable of improving antitumor activity with changed structure and its use |
| 07/25/2007 | CN1328286C Aglyco products and method of use |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN1327856C Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process |
| 07/25/2007 | CN1327844C Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor |
| 07/25/2007 | CN1327842C Novel compound antineoplastic drug preparing process |
| 07/25/2007 | CN101006180A Virus particle containing a vector derived from alpha virus and its preparation method |
| 07/25/2007 | CN101006172A Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 07/25/2007 | CN101006171A Anticancer agent containing minus-strand RNA virus |
| 07/25/2007 | CN101006090A Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof |
| 07/25/2007 | CN101006080A N CC-1065 analogues for use against cancers |
| 07/25/2007 | CN101006079A 嘧啶衍生物 Pyrimidine derivatives |
| 07/25/2007 | CN101006075A Bisarylurea derivatives useful for inhibiting CHK1 |
| 07/25/2007 | CN101006065A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 07/25/2007 | CN101006061A 1,5-diphenylpyrazoles |
| 07/25/2007 | CN101005850A Methods of using apo2l receptor agonists and nk cell activators |
| 07/25/2007 | CN101005844A Muscarinic antagonists with PARP and SIR modulatng activity as agents for inflammatory diseases |
| 07/25/2007 | CN101005843A Pyrrolotriazine kinase inhibitors |
| 07/25/2007 | CN101005840A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
| 07/25/2007 | CN101003816A Method for constructing straight nucleus expressed plasmid in PEX secretion type of human and application |
| 07/25/2007 | CN101003814A Constructing and expressing method for expression plasmid of recombined PEX pronucleus of human |
| 07/25/2007 | CN101003811A Citron gene of human, coding protein, and application |
| 07/25/2007 | CN101003805A C100F58 gene of human, its coding proteins, and application |
| 07/25/2007 | CN101003794A Method for constructing recombined adenovirus in PEX outer secretion type of human and application |
| 07/25/2007 | CN101003788A Anti tumor translocation peptide of scorpion, preparation method and application |
| 07/25/2007 | CN101003775A Method for producing health protection tea wine of ampelopsis grossedentata, and product |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003568A Recombined diphtheria toxin, preparation method, and application |
| 07/25/2007 | CN101003556A Derivative of 10 ¿C hydroxyl camptothecin, prepartion of its liposome, and preparation method |
| 07/25/2007 | CN101003548A Rosinyl diterpene modified alpha ¿C phosphoramidate, preparation method, and application for anti tumors |
| 07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 07/25/2007 | CN101003537A Derivative in pyrrolopyridazine category, preparation method, and application |
| 07/25/2007 | CN101003528A Diterpene compound and derivative in kaurene class of new disymmetry |
| 07/25/2007 | CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/25/2007 | CN101003514A Derivative of quinazoline, preparation method and usage |
| 07/25/2007 | CN101003513A Compound in quinazoline class or its pharmaceutical salt preparation method, and medical usage |
| 07/25/2007 | CN101003470A Analog of mono carbonyl structure of curcumin, and usage |
| 07/25/2007 | CN101003387A Method for preparing magnetic Nano composite granules coated by polyelectrolyte of positive ions |
| 07/25/2007 | CN101002946A Medicine for treating tumor, and its application |
| 07/25/2007 | CN101002945A Novel complexus used for treating tumor |
| 07/25/2007 | CN101002943A Conjugate of branched chain PEG-GCSF and PEG-GMCSF, and its preparing method |
| 07/25/2007 | CN101002941A Anticarcinogen composition carried with platinum compound and vasoinhibitor |
| 07/25/2007 | CN101002937A Recombinant His-IT-B7-H11gV tumor vaccine, and its preparing method |
| 07/25/2007 | CN101002931A Ubenimex tablet and its preparing method |
| 07/25/2007 | CN101002886A Fuliuping medicine composition for treating gynecopathy, and its application |
| 07/25/2007 | CN101002825A Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 07/25/2007 | CN101002812A Medical use of volatile oil of traditional Chinese medicine |
| 07/25/2007 | CN101002794A Super fine particle of amino-polysaccharide as antineoplastic, and its preparing method |
| 07/25/2007 | CN101002785A Antineoplastic composition, and process for preparing the same |
| 07/25/2007 | CN101002773A Use of hydrochloride coculine for preparing medicine to treat glioma |
| 07/25/2007 | CN101002772A Nanometer particle target preparation of hydroxycamptothecine, and its preparing method |
| 07/25/2007 | CN101002771A Self-assembly precursor liposome containing camptothecine medicine, and its preparing method |
| 07/25/2007 | CN101002768A Series preparation of swainsonine, preparing method and use thereof |